Maryline Barrié

3.4k total citations · 1 hit paper
53 papers, 1.9k citations indexed

About

Maryline Barrié is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, Maryline Barrié has authored 53 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Genetics, 19 papers in Pulmonary and Respiratory Medicine and 13 papers in Neurology. Recurrent topics in Maryline Barrié's work include Glioma Diagnosis and Treatment (39 papers), Brain Metastases and Treatment (16 papers) and Radiomics and Machine Learning in Medical Imaging (9 papers). Maryline Barrié is often cited by papers focused on Glioma Diagnosis and Treatment (39 papers), Brain Metastases and Treatment (16 papers) and Radiomics and Machine Learning in Medical Imaging (9 papers). Maryline Barrié collaborates with scholars based in France, Switzerland and United States. Maryline Barrié's co-authors include Olivier Chinot, Dominique Figarella‐Branger, Luc Taillandier, Diane Braguer, Pierre‐Marie Martin, Stéphanie Cartalat‐Carel, Jérôme Honnorat, Philippe Métellus, Karima Mokhtari and Jean‐Yves Delattre and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Maryline Barrié

51 papers receiving 1.9k citations

Hit Papers

Radiotherapy for Glioblastoma in the Elderly 2007 2026 2013 2019 2007 100 200 300 400 500

Peers

Maryline Barrié
Adriana Olar United States
Jane Rabbitt United States
Tianni Zhou United States
Rohan Ramakrishna United States
Kirsten Hopkins United Kingdom
L. S. Lashford United Kingdom
Sean Grimm United States
Maryline Barrié
Citations per year, relative to Maryline Barrié Maryline Barrié (= 1×) peers Matteo Simonelli

Countries citing papers authored by Maryline Barrié

Since Specialization
Citations

This map shows the geographic impact of Maryline Barrié's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maryline Barrié with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maryline Barrié more than expected).

Fields of papers citing papers by Maryline Barrié

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maryline Barrié. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maryline Barrié. The network helps show where Maryline Barrié may publish in the future.

Co-authorship network of co-authors of Maryline Barrié

This figure shows the co-authorship network connecting the top 25 collaborators of Maryline Barrié. A scholar is included among the top collaborators of Maryline Barrié based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maryline Barrié. Maryline Barrié is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Campello, Chantal, Maryline Barrié, Thomas Graillon, et al.. (2023). Radio-chemotherapy feasibility for biopsy-only unresectable IDH wild-type glioblastomas (BO-GBM). Neuro-Oncology Practice. 10(6). 536–543. 1 indexed citations
2.
Barrié, Maryline, Romain Appay, Marie Loosveld, et al.. (2023). Primary central nervous system lymphoma with initial spinal cord involvement (PCNSL-SC) is a rare entity: 4 case reports and review of literature. Revue Neurologique. 180(3). 224–229. 1 indexed citations
3.
Campello, Chantal, et al.. (2022). Prognostic value of circulating lymphocyte subsets in primary central nervous system lymphoma. Journal of Neuro-Oncology. 159(1). 15–22. 5 indexed citations
4.
Barrié, Maryline, Chantal Campello, Céline Boucard, et al.. (2019). Leptomeningeal Gliomatosis: A Single Institution Study of 31 Patients. Anticancer Research. 39(2). 1035–1041. 11 indexed citations
5.
Tabouret, Émeline, Céline Boucard, Maryline Barrié, et al.. (2015). Neuro-oncological patients admitted in intensive-care unit: predictive factors and functional outcome. Journal of Neuro-Oncology. 127(1). 111–117. 9 indexed citations
6.
Tabouret, Émeline, Françoise Boudouresque, Maryline Barrié, et al.. (2013). Association of matrix metalloproteinase 2 plasma level with response and survival in patients treated with bevacizumab for recurrent high-grade glioma. Neuro-Oncology. 16(3). 392–399. 47 indexed citations
7.
Tabouret, Émeline, Maryline Barrié, Anne C. M. Thiébaut, et al.. (2013). Limited impact of prognostic factors in patients with recurrent glioblastoma multiforme treated with a bevacizumab-based regimen. Journal of Neuro-Oncology. 114(2). 191–198. 26 indexed citations
8.
Tabouret, Émeline, Maryline Barrié, Cécile Vicier, et al.. (2012). Association of carcinoid tumor and low grade glioma. World Journal of Surgical Oncology. 10(1). 236–236. 1 indexed citations
9.
Colavolpe, C., Olivier Chinot, P. Métellus, et al.. (2012). FDG-PET predicts survival in recurrent high-grade gliomas treated with bevacizumab and irinotecan. Neuro-Oncology. 14(5). 649–657. 59 indexed citations
10.
Pérez‐Larraya, Jaime Gállego, François Ducray, Olivier Chinot, et al.. (2011). Temozolomide in Elderly Patients With Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial. Journal of Clinical Oncology. 29(22). 3050–3055. 160 indexed citations
11.
Colavolpe, C., Philippe Métellus, Julien Mancini, et al.. (2011). Independent prognostic value of pre-treatment 18-FDG-PET in high-grade gliomas. Journal of Neuro-Oncology. 107(3). 527–535. 37 indexed citations
12.
Giorgi, Roch, et al.. (2010). Links between private habits, psychological stress and brain cancer: a case–control pilot study in France. Journal of Neuro-Oncology. 103(2). 307–316. 32 indexed citations
13.
Guyotat, Jacques, Olivier Chinot, Anne Durand, et al.. (2010). Adult intracranial WHO grade II ependymomas: long-term outcome and prognostic factor analysis in a series of 114 patients. Neuro-Oncology. 12(9). 976–984. 59 indexed citations
14.
Carpentier, Alain, Philippe Métellus, Rénata Ursu, et al.. (2010). Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study. Neuro-Oncology. 12(4). 401–408. 163 indexed citations
15.
Colavolpe, C., Éric Guedj, Philippe Métellus, et al.. (2008). FDG-PET to predict different patterns of progression in multicentric glioblastoma: a case report. Journal of Neuro-Oncology. 90(1). 47–51. 12 indexed citations
16.
Guedj, Éric, Maryline Barrié, S. Fuentès, Olivier Chinot, & O. Mundler. (2008). A Case of Cerebello-Thalamo-Cortical Diaschisis. Clinical Nuclear Medicine. 33(10). 717–718. 1 indexed citations
17.
Keime-Guibert, Florence, Olivier Chinot, Luc Taillandier, et al.. (2007). Radiotherapy for Glioblastoma in the Elderly. New England Journal of Medicine. 356(15). 1527–1535. 535 indexed citations breakdown →
18.
Bartoloméi, Fabrice, Laurent Suchet, Maryline Barrié, & J L Gastaut. (1997). Alcoholic Epilepsy: A Unified and Dynamic Classification. European Neurology. 37(1). 13–17. 14 indexed citations
19.
Bartoloméi, Fabrice, Jean‐Philippe Azulay, Maryline Barrié, & J L Gastaut. (1996). Myoclonic Alcoholic Epilepsy. Epilepsia. 37(4). 406–409. 7 indexed citations
20.
Bartolomei, Fabrice, José Boucraut, Maryline Barrié, et al.. (1996). Cryptogenic Partial Epilepsies with Anti‐GM1 Antibodies: A New Form of Immune‐Mediated Epilepsy?. Epilepsia. 37(10). 922–926. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026